News

UC San Diego Highlighted in Governor's State of the State Address

January 24, 2014

UC San Diego Highlighted in Governor's State of the State Address

As Governor Edmund G. Brown Jr. delivered his annual State of the State address to the Legislature yesterday, he highlighted the University of California, San Diego as a leader in developing medical and scientific advances. In prepared remarks, Gov. Brown noted, “Four out of the world’s 20 leading academic bioscience institutions are located here in California: UCSF and Berkeley, UCLA, Stanford and UC San Diego. Just as California has led the way with stem cell research, so too can we pioneer the new field of precision medicine which uses genomics, medical devices, computer sciences and other fields to treat individual patients, instead of broad populations.” Full Story


Single-Cell Genome Sequencing Gets Better

January 14, 2014

Single-Cell Genome Sequencing Gets Better

Bioengineers at the Jacobs School have created a better way to sequence genomes from individual cells. The breakthrough, which relies on microwells just 12 nanoliters in volume (see image below), is one of many recent "omics" innovations from researchers across the Jacobs School and UC San Diego. The single-cell genome sequencing advance from Kun Zhang's lab could help researchers understand what causes Alzheimer's disease. The work could also enable scientists to identify tough-to-culture microbes living in ocean water and within the human body-by probing single cells. Full Story


Color Block

January 9, 2014

How to Manage Mobile Medical App Development Under FDA Regulation

A consortium of six leading universities, more than a dozen industry trade associations and professional societies, and the U.S. Food & Drug Administration announced their unprecedented collaboration to develop a series of educational programs designed to help mobile app developers learn about FDA requirements for producing higher risk medical apps as well as the business issues associated with entering this space.Called the “MMA Roadshow:  Managing App Development under FDA Regulation,” the four-hour workshops are scheduled over several months across the country, including Jan. 27 at the University of California, San Diego. Full Story


Biomaterials Get Stem Cells to Commit to a Bony Future

January 6, 2014

Biomaterials Get Stem Cells to Commit to a Bony Future

With the help of biomimetic matrices, a research team led by bioengineers at the University of California, San Diego has discovered exactly how calcium phosphate can coax stem cells to become bone-building cells. This work is published in the Proceedings of the National Academy of Sciences the week of Jan. 6, 2014. Full Story


2013: The Year in Review

December 13, 2013

2013: The Year in Review

From the largest alumni gift in the campus’ history, which went to the Department of Computer Science and Engineering, to the arrival of Dean Al Pisano, it’s been a busy year here at the Jacobs School of Engineering. The school produced many research milestones, from a Google map of the human metabolism to the world’s first zoomable contact lens. Students got into the action too and UC San Diego became the first university to design, build and test a 3D-printed rocket engine. Here are some of the most memorable stories of the year—but not all: the list would be too long.  Full Story


Bioengineering Professor Among Six UC San Diego Faculty Named 2013 AAAS Fellows

November 25, 2013

Bioengineering Professor Among Six UC San Diego Faculty Named 2013 AAAS Fellows

Six professors at the University of California, San Diego have been named 2013 Fellows of the American Association for the Advancement of Science, the nation’s largest general science organization. Full Story


New Models Predict Where E. coli Strains Will Thrive

November 18, 2013

New Models Predict Where E. coli Strains Will Thrive

Bioengineers at the University of California, San Diego have used the genomic sequences of 55 E. coli strains to reconstruct the metabolic repertoire for each strain. Surprisingly, these reconstructions do an excellent job of predicting the kind of environment where each strain will thrive, the researchers found. Their analysis, published in the Nov. 18, 2013 early edition of the Proceedings of the National Academy of Sciences, could prove useful in developing ways to control deadly E. coli infections and to learn more about how certain strains of the bacteria become virulent. Full Story


Single-Cell Genome Sequencing Gets Better

November 12, 2013

Single-Cell Genome Sequencing Gets Better

Researchers led by bioengineers at the University of California, San Diego have generated the most complete genome sequences from single E. coli cells and individual neurons from the human brain. The breakthrough comes from a new single-cell genome sequencing technique that confines genome amplification to fluid-filled wells with a volume of just 12 nanoliters.  Full Story


Genomatica Among 100 Companies Highlighted for Economic Boost of Research

October 30, 2013

Genomatica Among 100 Companies Highlighted for Economic Boost of Research

Two innovative UC San Diego spinoffs are among the 100 companies cited by The Science Coalition in a new report touting the positive economic payoff of federally funded university research. Genomatica, a biotechnology company that grew from research conducted in Bernhard Palsson’s laboratory at UC San Diego; and Senomyx, a provider of flavor ingredients for the food and beverage industries that arose from research conducted by Charles Zuker at UC San Diego, help demonstrate how support of basic and applied research at American universities pays strong economic dividends. Full Story


Bioinformatics Breakthrough: High Quality Transcriptome from as Few as Fifty Cells

October 22, 2013

Bioinformatics Breakthrough: High Quality Transcriptome from as Few as Fifty Cells

Bioengineers from the University of California, San Diego have created a new method for analyzing RNA transcripts from samples of 50 to 100 cells. The approach could be used to develop inexpensive and rapid methods for diagnosing cancers at early stages, as well as better tools for forensics, drug discovery and developmental biology. Full Story